Shagun Singh
Stock Analyst at RBC Capital
(2.65)
# 1,943
Out of 4,825 analysts
200
Total ratings
49.71%
Success rate
-0.13%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Sector Perform | $150 → $145 | $126.26 | +14.84% | 20 | May 2, 2025 | |
| ZYXI Zynex | Maintains: Sector Perform | $5 → $4 | $2.30 | +73.91% | 7 | Apr 30, 2025 | |
| PEN Penumbra | Maintains: Outperform | $315 → $330 | $296.47 | +11.31% | 12 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $116 → $120 | $104.93 | +14.36% | 15 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $630 → $605 | $529.42 | +14.28% | 14 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $140 → $145 | $132.82 | +9.17% | 13 | Apr 17, 2025 | |
| JNJ Johnson & Johnson | Reiterates: Outperform | $181 | $156.12 | +15.94% | 20 | Apr 16, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $260 → $215 | $159.29 | +34.97% | 5 | Apr 15, 2025 | |
| PODD Insulet | Initiates: Outperform | $340 | $257.00 | +32.30% | 1 | Mar 6, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Outperform | $65 → $55 | $21.45 | +156.41% | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $105 | $84.85 | +23.75% | 20 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $75.53 | +12.55% | 21 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 → $125 | $102.05 | +22.49% | 13 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $378.22 | +15.01% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $45 | $12.19 | +269.16% | 9 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $71.90 | +27.96% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $81.62 | +40.90% | 4 | Oct 25, 2024 |
Teleflex
May 2, 2025
Maintains: Sector Perform
Price Target: $150 → $145
Current: $126.26
Upside: +14.84%
Zynex
Apr 30, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.30
Upside: +73.91%
Penumbra
Apr 24, 2025
Maintains: Outperform
Price Target: $315 → $330
Current: $296.47
Upside: +11.31%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $104.93
Upside: +14.36%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $630 → $605
Current: $529.42
Upside: +14.28%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $140 → $145
Current: $132.82
Upside: +9.17%
Johnson & Johnson
Apr 16, 2025
Reiterates: Outperform
Price Target: $181
Current: $156.12
Upside: +15.94%
Inspire Medical Systems
Apr 15, 2025
Maintains: Outperform
Price Target: $260 → $215
Current: $159.29
Upside: +34.97%
Insulet
Mar 6, 2025
Initiates: Outperform
Price Target: $340
Current: $257.00
Upside: +32.30%
Tandem Diabetes Care
Feb 27, 2025
Maintains: Outperform
Price Target: $65 → $55
Current: $21.45
Upside: +156.41%
Feb 19, 2025
Reiterates: Outperform
Price Target: $105
Current: $84.85
Upside: +23.75%
Feb 12, 2025
Reiterates: Outperform
Price Target: $85
Current: $75.53
Upside: +12.55%
Feb 7, 2025
Maintains: Outperform
Price Target: $130 → $125
Current: $102.05
Upside: +22.49%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $378.22
Upside: +15.01%
Jan 7, 2025
Reiterates: Sector Perform
Price Target: $45
Current: $12.19
Upside: +269.16%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $71.90
Upside: +27.96%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $81.62
Upside: +40.90%